Black Swan Analysis is attending the BioTrinity Conference: Vision for Life Sciences 2030, London on the 25th – 27th April

On March 23, 2016, In News

BioTrinity is Europe’s leading investment and bio-partnering conference and provides a unique platform for companies across the life sciences industry to achieve their business objectives, secure funding, seek acquisition and in-licensing deals and grow their network.

As BioTrinity is celebrating its 10th year the theme for the event is Vision for Life Sciences 2030.  The aim being to helping companies work together in meeting the challenges within a rapidly changing global environment.

As experts in Dynamic Market Forecasting, Black Swan Analysis is able to creating multi-market models with scenario planning and predictive analytics to help determine business landscapes of the future.

Please let us know if you would like to arrange a meeting in or around the conference:

Please note we provide a 20% discount to all OBN members on the purchase of all Epiomic™ Epidemiology Series reports, Epiomic Insights and Epiomic online database subscriptions to our disease epidemiology and hospital procedures.